“Money matters,” says the $3 billion California stem cell
agency. And it is right.
The agency was commenting yesterday on a study published this week that indicated that the Golden State has “over-performed”in terms of publication of research findings as the result of the agency’s
efforts.
The comment appeared on The Stem Cellar, the agency’s blog.
Kevin McCormack, senior director of communications, wrote,
“The question the researchers posed was; have the states that fund stem cell research seen an increase in their share of scientific publications in the field? The answer, at least in California’s case, is absolutely yes.”
The study by Aaron Levine of Georgia Tech said its findings “suggested”
that the increase was due to 667 awards totaling $1.9 billion made by the stem
cell agency over the last 10 years.
As Levine’s article noted, many other factors need to be
examined to determine whether the agency has met the goals of the
2004 ballot campaign that created the stem cell research effort. But for now, the piece by Levine is a significant plus for the California Institute for
Regenerative (CIRM), as the agency is formally known. And it comes from an
independent source, one that is not financed by the agency, as some other
studies have been.
No comments:
Post a Comment